Vascular behcet and mutations in thrombogenic genes: Methylene tetrahydrofolate reductase, factor V, and prothrombin

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 1, 2012, Pages 30-35

  Dagan, Efrat ^a,b   Baruch, Yoav ^c   Fiorilli, Massimo ^c   Rozenbaum, Michael ^d,e   Rosner, Itzhak ^d,e   Gershoni Baruch, Ruth ^b,e  

^a UNIVERSITY OF HAIFA   (Israel)

^b Institute of Human Genetics   (Israel)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d BNAI ZION MEDICAL CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARAB; ARTICLE; BEHCET DISEASE; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HOMOZYGOTE; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE;

ADOLESCENT; ADULT; BEHCET SYNDROME; FACTOR V; FEMALE; GENES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; THROMBOSIS; VASCULAR DISEASES; YOUNG ADULT;

EID: 84856258887     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0096     Document Type: Article

References (45)

1. Ahn JK, Lee YS, Jeon CH, et al. (2008) Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27:201-205.
2. Ames PR, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) 40:652-655.
3. Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21:S35-S37. (Pubitemid 37193095)
4. Atesx A, Düzgün N, Ulu A, et al. (2003) Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease. Pathophysiol Haemost Thromb 33:157-163. (Pubitemid 38698116)
5. Ayesh S, Abu-Rmaileh H, Nassar S, et al. (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease. Scand J Rheumatol 37:370-374.
6. Bayraktar Y, Soylu AR, Balkanci F, et al. (1998) Arterial thrombosis leading to intestinal infarction in a patient with Behçet's disease associated with protein C deficiency. Am J Gastroenterol 93:2556-2558. (Pubitemid 29018572)
7. Bertina RM (1997) Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 43:1678-1683. (Pubitemid 27396369)
8. Bertina RM, Koeleman BP, Koster T, et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67. (Pubitemid 24144355)
9. Bertina RM, van Tilburg NH, de Foue NJ, Haverkate F (1992) Thrombin, a link between coagulation activation and fibrinolysis. Ann NY Acad Sci 667:239.
10. Caramaschi P, Poli G, Bonora A, et al. (2010) A study on thrombophilic factors in Italian Behcet's patients. Joint Bone Spine 77:330-334.
11. Chafa O, Fischer AM, Meriane F, et al. (1992) Behçet syndrome associated with protein S deficiency. Thromb Haemost 67:1-3.
12. Dagan E, Brik R, Broza Y, Gershoni-Baruch R (2006) Henoch- Schonlein purpura: polymorphisms in thrombophilia genes. Pediatr Nephrol 21:1117-1121. (Pubitemid 44083884)
13. Ehrlich GE (1997) Vasculitis in Behçet's disease. Int Rev Immunol 14:81-88.
14. Espinosa G, Cervera R, Reverter JC, et al. (2002) Vascular involvement in Behçet's disease. Isr Med Assoc J 4:614-616.
15. Espinosa G, Font J, Tàssies D, et al. (2002) Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112: 37-43. (Pubitemid 34113853)
16. Frosst P, Blom HJ, Milos R, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
17. Guermazi S, M'Rad S, Lamloum M, et al. (1998) Activated protein C resistance in Behçet disease. Pathol Biol 46:791-795. (Pubitemid 29029371)
18. Houman MH, Ben Ghorbel I, Khiari Ben Salah I, et al. (2001) Deep vein thrombosis in Behçet's disease. Clin Exp Rheumatol 19:S48-S50. (Pubitemid 33730228)
19. Imirzalioglu N, Dursun A, Tastan B, et al. (2005) MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 34:56-58. (Pubitemid 40445060)
20. International Study Group for Behcet's Disease (ISBD) (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078- 1080.
21. Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Behcet's disease. Semin Arthritis Rheum 27:197-217. (Pubitemid 28154646)
22. Kapsimali VD, KanakisMA, Vaiopoulos GA, Kaklamanis PG(2010) Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations. Clin Rheumatol 29:1211-1216.
23. Kiraz S, Ertenli I, Oztürk MA, et al. (2002) Pathological haemostasis and "prothrombotic state" in Behçet's disease. Thromb Res 105:125-133. (Pubitemid 34214927)
24. Krause I, Mader R, Sulkes J, et al. (2001) Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 28:1033-1036. (Pubitemid 32422584)
25. Koç Y, Güllü I, Akpek G, et al. (1992) Vascular involvement in Behçet's disease. J Rheumatol 19:402-410.
26. Koné-Paut I, Sanchez E, Le Quellec A, et al. (2007) Autoinflammatory gene mutations in Behcet's disease. Ann Rheum Dis 66:832-834. (Pubitemid 46846709)
27. La Regina M, Orlandini F, Prisco D, Dentali F (2010) Homocysteine in Vascular Behcet Disease. A Meta-Analysis. Arterioscler Thromb Vasc Biol 30:2067-2074.
28. Leiba M, Seligsohn U, Sidi Y, et al. (2004) Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 63:1445-1449. (Pubitemid 39433949)
29. Mader R, Ziv M, Adawi M, et al. (1999) Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol 26:2404-2408. (Pubitemid 29528982)
30. Mendoza-Pinto C, García-Carrasco M, Jiménez- Hernández M, et al. (2010) Etiopathogenesis of Behcet's disease. Autoimmun Rev 9:241-245.
31. Nalçaci M, Pekçelen Y (1998) Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease. J Int Med Res 26:206-208. (Pubitemid 28477157)
32. Navarro S, Ricart JM, Medina P, et al. (2004) Activated protein C levels in Behçet's disease and risk of venous thrombosis. Br J Haematol 126:550-556. (Pubitemid 39093098)
33. O'Duffy JD (1994) Behcet's disease. Curr Opin Rheumatol 6:39-43. (Pubitemid 24148577)
34. Oner AF, Gürgey A, Gürler A, Mesci L (1998) Factor V Leiden mutation in patients with Behçet's disease. J Rheumatol 25:496-498. (Pubitemid 28109352)
35. Ozkul Y, Evereklioglu C, Borlu M, et al. (2005) 5,10- Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br J Ophthalmol 89:1634-1637. (Pubitemid 41729911)
36. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703. (Pubitemid 26383091)
37. Rabinovich E, Shinar Y, Leiba M, et al. (2007) Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48-52. (Pubitemid 46572912)
38. Ricart JM, Vayá A, Todolí J, et al. (2006) Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 95:618-614.
39. Shehto NM, Ghosh K, Abdul Kader B, al Assad HS (1992) Extensive venous thrombosis in a case of Behçet's disease associated with heterozygous protein C deficiency. Thromb Haemost 67:283.
40. Silingardi M, Salvarani C, Boiardi L, et al. (2004) Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum 51:177-183. (Pubitemid 38468699)
41. Touitou I, Magne X, Molinari N, et al. (2000) MEFV mutations in Behçet's disease. Hum Mutat 16:271-272.
42. Toydemir PB, Elhan AH, Tükün A, et al. (2000) Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. J Rheumatol 27:2849-2854.
43. Uthman I, Otrock Z, Taher A (2006) Deep venous thrombosis in a patient with Behcet's disease and homozygous prothrombin (factor II) G20210A mutation on oral contraceptive pills. Rheumatol Int 26:758-759. (Pubitemid 43725471)
44. Yazici H, Fresko I, Yurdakul S (2007) Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148-155. (Pubitemid 46416263)
45. Zoller B, Svensson PJ, He X, Dahlback B (1994) Identification of the same factor V gene mutation protein C. J Clin Invest 94:2521-2524.